Research shows that metabolic surgery and GLP-1 (glucagon-like peptide 1) medications are both effective therapies for treating obesity.
Medications typically result in a 10% loss of body weight in a real-world setting, while surgery can achieve more dramatic results, up to 25% to 30%.
Metabolic experts at Mayo Clinic in the United States say that combining the two in some instances can be an effective way to treat obesity.
“Obesity is a disease, and to overcome it, we need to use all the modalities, or tools, we have available,” says metabolic surgeon Dr Omar Ghanem.
However, it’s not a one-size-fits-all approach.
“Some patients might benefit only from medications, some patients might benefit only from surgery, but a portion of patients might benefit from the combined therapy,” he says.
He says that some patients experience greater weight loss when combining bariatric surgery, also called metabolic surgery, with GLP-1 medications.
Ideal candidates include patients who start obesity treatment with a higher body mass index (BMI); those who are preparing to undergo a complex surgical procedure, such as a transplant; and patients who need to lose more weight for their overall health, or those looking to maintain their weight after metabolic surgery.
“Neither GLP-1s nor bariatric surgery are magic.
“These are tools, and the patient has to use those tools correctly to be able to overcome obesity,” Dr Ghanem says.
“Each case is different.
“Go to your provider, talk to your specialist, and trust them to help you make the right decision for your health.
“Our patients have to put a lot of effort to overcome the disease.
“They’re not just choosing the easy way out, they’re choosing the healthy way out.” – Mayo Clinic News Network/Tribune News Service
